Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma.
2016
We report the occurrence of autoimmune hemolytic anemia in a patient receiving the anti-PD-1 monoclonal antibody, nivolumab, for metastatic melanoma in the presence of known red cell alloantibodies, despite having received prior ipilimumab without evidence of hemolysis. The patient had a history of
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
67
Citations
NaN
KQI